Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Lyman

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Journal of General Internal Medicine|September 1, 1994
The effect of changing disease risk on clinical reasoningG H Lyman, L Balducci
Current Opinion in Hematology|May 5, 1999
Update of the economic analyses of the use of the colony-stimulating factorsG H Lyman, L Balducci
Oncology (Williston Park, N.Y.)|November 1, 1995
A cost analysis of hematopoietic colony-stimulating factorsG H Lyman, L Balducci
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2020
Personalized cancer supportive care in COVID-19 eraG H Lyman, N M Kuderer
Pharmacotherapy|July 25, 2000
Interactive discussion on chemotherapy-related adverse eventsV R Adams, G H Lyman
American Journal of Hematology|January 1, 1977
Acute myelogenous leukemia subsequent to therapy for a different neoplasm: clinical features and response to therapyH D Preisler, G H Lyman
Hematological Oncology|January 1, 1992
Advances in current cancer treatment: an overviewG H Lyman, A S Spiers
JAMA|November 21, 1986
Leukemia and groundwater contaminationG H Lyman, C G Lyman
Journal of Medicine|January 1, 1978
Carcinoma of unknown primary: natural history and response to therapyG H Lyman, H D Preisler
Critical Reviews in Oncology/Hematology|May 26, 2004
The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropeniaG H Lyman, N M Kuderer
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Journal of General Internal Medicine|September 1, 1994
The effect of changing disease risk on clinical reasoningG H Lyman, L Balducci
Current Opinion in Hematology|May 5, 1999
Update of the economic analyses of the use of the colony-stimulating factorsG H Lyman, L Balducci
Oncology (Williston Park, N.Y.)|November 1, 1995
A cost analysis of hematopoietic colony-stimulating factorsG H Lyman, L Balducci
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2020
Personalized cancer supportive care in COVID-19 eraG H Lyman, N M Kuderer
Pharmacotherapy|July 25, 2000
Interactive discussion on chemotherapy-related adverse eventsV R Adams, G H Lyman
American Journal of Hematology|January 1, 1977
Acute myelogenous leukemia subsequent to therapy for a different neoplasm: clinical features and response to therapyH D Preisler, G H Lyman
Hematological Oncology|January 1, 1992
Advances in current cancer treatment: an overviewG H Lyman, A S Spiers
JAMA|November 21, 1986
Leukemia and groundwater contaminationG H Lyman, C G Lyman
Journal of Medicine|January 1, 1978
Carcinoma of unknown primary: natural history and response to therapyG H Lyman, H D Preisler
Critical Reviews in Oncology/Hematology|May 26, 2004
The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropeniaG H Lyman, N M Kuderer
Pageof 13